Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Angelika Banzhoff
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Concepts & Ideas
Disorders
Procedures
Chemicals & Drugs
Living Beings
Anatomy
Phenomena
Sign-in to see full Profile
Network (preview)
11
Zent, Olaf
9
Jilg, Wolfgang
7
Nicolay, Uwe
6
Malerczyk, Claudius
4
Plentz, Annelie
4
Podda, Audino
4
Beran, Jiri
4
Girgsdies, OE
3
Brauer, V F H
3
Briggs, Deborah
3
Schöndorf, Ines
3
Schwarz, Tino
3
Schwenke, C
2
Nacci, Pantaleo
2
Rappuoli, Rino
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Angelika Banzhoff (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Alberini Isabella; Del Tordello Elena; Fasolo Alba; Temperton Nigel J; Galli Grazia; Gentile Chiara; Montomoli Emanuele; Hilbert Anne K; Banzhoff Angelika; Del Giudice Giuseppe; Donnelly John J; Rappuoli Rino; Capecchi Barbara
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses.
Vaccine 2009;27(43):5998-6003.
-
2009: Galli Grazia; Hancock Kathy; Hoschler Katja; DeVos Joshua; Praus Michaela; Bardelli Monia; Malzone Carmine; Castellino Flora; Gentile Chiara; McNally Teresa; Del Giudice Giuseppe; Banzhoff Angelika; Brauer Volker; Montomoli Emanuele; Zambon Maria; Katz Jacqueline; Nicholson Karl; Stephenson Iain
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(19):7962-7.
-
2009: Galli Grazia; Medini Duccio; Borgogni Erica; Zedda Luisanna; Bardelli Monia; Malzone Carmine; Nuti Sandra; Tavarini Simona; Sammicheli Chiara; Hilbert Anne K; Brauer Volker; Banzhoff Angelika; Rappuoli Rino; Del Giudice Giuseppe; Castellino Flora
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(10):3877-82.
-
2009: Banzhoff Angelika; Gasparini Roberto; Laghi-Pasini Franco; Staniscia Tommaso; Durando Paolo; Montomoli Emanuele; Capecchi Pier Leopoldo; di Giovanni Pamela; Sticchi Laura; Gentile Chiara; Hilbert Anke; Brauer Volker; Tilman Sandrine; Podda Audino
MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults.
PloS one 2009;4(2):e4384.
-
2008: Banzhoff Angelika; Pellegrini Michele; Del Giudice Giuseppe; Fragapane Elena; Groth Nicola; Podda Audino
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.
Influenza and other respiratory viruses 2008;2(6):243-9.
-
2008: Banzhoff Angelika; Bröker Michael; Zent Olaf
Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas.
Travel medicine and infectious disease 2008;6(6):331-41.
-
2008: Stephenson Iain; Nicholson Karl G; Hoschler Katja; Zambon Maria C; Hancock Kathy; DeVos Joshua; Katz Jacqueline M; Praus Michaela; Banzhoff Angelika
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.
The New England journal of medicine 2008;359(15):1631-3.
-
2007: Kamoltham Thavatchai; Thinyounyong Wirawan; Phongchamnaphai Phana; Phraisuwan Phran; Khawplod Pakamatz; Banzhoff Angelika; Malerczyk Claudius
Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
The Journal of pediatrics 2007;151(2):173-7.
-
2007: Schoendorf Ines; Ternak Gabor; Oroszlàn György; Nicolay Uwe; Banzhoff Angelika; Zent Olaf
Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21).
Human vaccines 2007;3(2):42-7.
-
2007: Schöndorf I; Beran J; Cizkova D; Lesna V; Banzhoff A; Zent O
Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
Vaccine 2007;25(8):1470-5.
-
2007: Malerczyk Claudius; Briggs Deborah J; Dreesen David W; Banzhoff Angelika
Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
Journal of travel medicine 2007;14(1):63-4.
-
2007: Schöndorf Ines; Banzhoff Angelika; Nicolay Uwe; Diaz-Mitoma Francisco
Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: A controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate, stored at room temperature for 6 months.
Vaccine 2007;25(7):1175-82.
-
2006: Ambrozaitis Arvydas; Laiskonis Alvydas; Balciuniene Ligita; Banzhoff Angelika; Malerczyk Claudius
Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Vaccine 2006;24(19):4116-21.
-
2006: Schöndorf Ines; Schönfeld Christian; Nicolay Uwe; Zent Olaf; Banzhoff Angelika
Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
International journal of medical microbiology : IJMM 2006;296 Suppl 40():208-12.
-
2006: Beran Jiri; Honegr Karel; Banzhoff Angelika; Malerczyk Claudius
How far can the antigen content of tissue culture rabies vaccine be reduced safely?
Vaccine 2006;24(13):2223-4.
-
2005: Beran Jiri; Honegr Karel; Banzhoff Angelika; Malerczyk Claudius
Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine.
Vaccine 2005;23(30):3902-7.
-
2005: Zent Olaf; Hennig Renald; Banzhoff Angelika; Bröker Michael
Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers.
Journal of travel medicine 2005;12(2):85-93.
-
2005: Quiambao Beatriz P; Dimaano Efren M; Ambas Cristina; Davis Rolan; Banzhoff Angelika; Malerczyk Claudius
Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals.
Vaccine 2005;23(14):1709-14.
-
2004: Rendi-Wagner Pamela; Kundi M; Zent O; Banzhoff A; Jaehnig P; Stemberger R; Dvorak G; Grumbeck E; Laaber B; Kollaritsch H
Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation.
Vaccine 2004;23(4):427-34.
-
2004: Zent Olaf; Plentz Annelie; Schwarz Tino F; Frühwein Nikolaus; Kuhr Hans B; Broeker Michael; Banzhoff Angelika; Jilg Wolfgang
TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
Vaccine 2004;23(3):312-5.
-
2004: Zent Olaf; Schwarz Tino F; Plentz Annelie; Banzhoff Angelika; Jilg Wolfgang
TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
International journal of medical microbiology : IJMM 2004;293 Suppl 37():134-8.
-
2004: Zent O; Wittermann Ch; Banzhoff A; Plentz A; Jilg W
[New TBE vaccine formulations--free of proteineous stabilizer and preservatives. Overview of clinical studies and first year post-marketing experience]
MMW Fortschritte der Medizin 2004;146(3-4):43.
-
2004: Matjila Maila J; Phohu Thabo C; Banzhoff Angelika; Viviani Simonetta; Hoosen Anwar A; Bianchini Massimo; Nacci Pantaleo; Palweni Chapman W; Podda Audino; Whitfield Michael; Aspinall Sanet
Safety and immunogenicity of two Haemophilus influenzae type b conjugate vaccines.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2004;94(1):43-6.
-
2003: Zent Olaf; Jilg Wolfgang; Plentz Annelie; Schwarz Tino F; Frühwein Nikolaus; Kuhr Hans B; Banzhoff Angelika
Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule.
Vaccine 2003;21(32):4655-60.
-
2003: Zent O; Banzhoff A; Hilbert A K; Meriste S; Sluzewski W; Wittermann Ch
Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
Vaccine 2003;21(25-26):3584-92.
-
2003: Banzhoff Angelika; Nacci Pantaleo; Podda Audino
A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis.
Gerontology 2003;49(3):177-84.
-
2003: Zent Olaf; Beran Jiri; Jilg Wolfgang; Mach Tomasz; Banzhoff Angelika
Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults.
Vaccine 2003;21(7-8):738-41.
-
2001: Banzhoff A; Donner-Banzhoff N; Schwenke C; Girgsdies O E; Jilg W
[Combined vaccine against tetanus, diphtheria and polio. A randomized controlled study of immunogenicity and tolerance]
Fortschritte der Medizin. Originalien 2001;118(4):169-72.
-
2000: Briggs D J; Dreesen D W; Nicolay U; Chin J E; Davis R; Gordon C; Banzhoff A
Purified Chick Embryo Cell Culture Rabies Vaccine: interchangeability with Human Diploid Cell Culture Rabies Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons.
Vaccine 2000;19(9-10):1055-60.
-
2000: Banzhoff A; Donner-Banzhoff N; Schwenke C; Girgsdies O E; Jilg W
[Combined vaccine against polio, diphtheria and tetanus. Closing vaccination gaps!]
MMW Fortschritte der Medizin 2000;142(48):54.
-
2000: Banzhoff A; Schwenke C; Febbraro S
Preservative-free influenza vaccine.
Immunology letters 2000;71(2):91-6.
-
2000: Nicolay U; Girgsdies O E; Banzhoff A; Hundt E; Kondler-Budde R; Lober R; Hainz R; Jilg W
[Diphtheria antitoxin level 2 years after booster vaccination]
Wiener medizinische Wochenschrift (1946) 2000;150(22):435-9.
-
2000: Briggs D J; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
Bulletin of the World Health Organization 2000;78(5):693-8.
-
1999: Nicolay U; Girgsdies O E; Banzhoff A; Hundt E; Jilg W
Diphtheria booster vaccination: one or two injections?
Vaccine 1999;17(18):2223-8.
Sign-in to see more
